Company news
Arecor Therapeutics PLC news in 2022
Arecor Therapeutics PLC's news releases, calls and decks from 2022, newest first.
Tetris pharma service agreement with Syneos Health
December 12, 2022
Grant of LTIP Options and PDMR Dealing
December 6, 2022
Arecor to commence second trial with AT278
November 22, 2022
Arecogranted patent in Japan and South Korea
November 22, 2022
Grant of AESOP Options and PDMR Dealing
November 17, 2022
Arecor Therapeutics scientist hopeful that arti...
November 15, 2022
Specialty hospital formulation collaboration
November 10, 2022
Exercise of options and PDMR dealing
November 8, 2022
Tetris pharma launches Ogluo® in Germany
November 1, 2022
Headline results from Phase I trial of AT247
October 11, 2022
Arecor Presents Positive Data for AT278 at EASD
September 20, 2022
Interim Results for six months ended 30 June 2022
September 8, 2022
Arecor granted European patents
August 9, 2022
Director/PDMR Dealings
August 4, 2022
Result of Placing
August 1, 2022
Proposed Acquisition of Tetris Pharma Ltd
August 1, 2022
Arecor announces presentation at EASD 2022
July 4, 2022
Arecor collaborates with top global pharma company
June 16, 2022
Result of agm
May 23, 2022
Arecor AGM statement
May 23, 2022
Arecor to host kol webinar
May 18, 2022
Arecor presents AT278 Phase I data at ATTD meeting
April 28, 2022
Arecor 2021 annual report and notice of AGM
April 27, 2022
Final results for the year ended 31 December 2021
April 25, 2022
Arecor announces oral presentation at ATTD 2022
April 12, 2022
Notice of Preliminary Results
March 29, 2022
Arecor wins at CambridgeshireLive Business Awards
March 28, 2022
Arecor provides business update
January 20, 2022
Arecor commences US Phase I trial of AT247
January 20, 2022
Calls in 2022
Decks in 2022
- FY2021 Earnings Presentation
Earnings · 23 slides · Apr 25, 2022